Evidence map›Paper›PMID 29420639›Full record

ArticlePloS one2018

Cognitive dysfunction in naturally occurring canine idiopathic epilepsy.

Rowena M A Packer, Paul D McGreevy, Hannah E Salvin, Michael J Valenzuela, Chloe M Chaplin, Holger A Volk

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Epilepsy in British Shorthair cats in Sweden.Journal of feline medicine and surgery · 2022
    Article
  18. Myoclonus in older Cavalier King Charles Spaniels.Journal of veterinary internal medicine · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rowena M A PackerDepartment of Clinical Science and Services, Royal Veterinary College, Hatfield, Hertfordshire, United Kingdom.ORCID 0000-0002-9988-9828
Paul D McGreevySydney School of Veterinary Science, Faculty of Science, The University of Sydney, New South Wales, Australia.
Hannah E SalvinSydney School of Veterinary Science, Faculty of Science, The University of Sydney, New South Wales, Australia.
Michael J ValenzuelaBrain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.
Chloe M ChaplinDepartment of Clinical Science and Services, Royal Veterinary College, Hatfield, Hertfordshire, United Kingdom.
Holger A VolkDepartment of Clinical Science and Services, Royal Veterinary College, Hatfield, Hertfordshire, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BB/P001874/1Biotechnology and Biological Sciences Research Council BB/P010881/1
6 · The paper itself

Abstract

Globally, epilepsy is a common serious brain disorder. In addition to seizure activity, epilepsy is associated with cognitive impairments including static cognitive impairments present at onset, progressive seizure-induced impairments and co-morbid dementia. Epilepsy occurs naturally in domestic dogs but its impact on canine cognition has yet to be studied, despite canine cognitive dysfunction (CCD) recognised as a spontaneous model of dementia. Here we use data from a psychometrically validated tool, the canine cognitive dysfunction rating (CCDR) scale, to compare cognitive dysfunction in dogs diagnosed with idiopathic epilepsy (IE) with controls while accounting for age. An online cross-sectional study resulted in a sample of 4051 dogs, of which n = 286 had been diagnosed with IE. Four factors were significantly associated with a diagnosis of CCD (above the diagnostic cut-off of CCDR ≥50): (i) epilepsy diagnosis: dogs with epilepsy were at higher risk; (ii) age: older dogs were at higher risk; (iii) weight: lighter dogs (kg) were at higher risk; (iv) training history: dogs with more exposure to training activities were at lower risk. Impairments in memory were most common in dogs with IE, but progression of impairments was not observed compared to controls. A significant interaction between epilepsy and age was identified, with IE dogs exhibiting a higher risk of CCD at a young age, while control dogs followed the expected pattern of low-risk throughout middle age, with risk increasing exponentially in geriatric years. Within the IE sub-population, dogs with a history of cluster seizures and high seizure frequency had higher CCDR scores. The age of onset, nature and progression of cognitive impairment in the current IE dogs appear divergent from those classically seen in CCD. Longitudinal monitoring of cognitive function from seizure onset is required to further characterise these impairments.

Indexed as

Age FactorsAnimalsCognition DisordersDog DiseasesDogsEpilepsy

Identifiers

PMID29420639
PMCPMC5805257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.